Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-13-049193)

Filing Details

Accession Number:: 0001144204-13-049193
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-09-04 13:59:56
Reporting Period:: 2013-04-16

Filing Date:: 2013-09-04
Accepted Time:: 2013-09-04 13:59:56
Original Submission Date:: 2013-07-23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1420030	Targeted Medical Pharma Inc.	TRGM	Pharmaceutical Preparations (2834)	205863618

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509917	William Shell	C/O Targeted Medical Pharma, Inc. 2980 Beverly Glen Circle, Suite 301 Los Angeles CA 90077	Ceo & Chief Scientific Officer	Yes	Yes	Yes	No
1511770	Trust Family Shell William & Charuvastra Elizabeth	3048 Nicada Drive Los Angeles CA 90077		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.001 Par Value Per Share	Acquisiton	2013-06-20	28,100	$1.15	651,054	No	4	P	Indirect	By trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $.001 Par Value Per Share	622,954	Indirect	By trust

Footnotes

Common stock and warrants are held by Willliam Shell Survivor's Trust.
On July 23, 2013, the reporting person mistakenly filed a Form 4 without including his purchase of 28,100 shares of Targeted Medical Pharma, Inc. Such purchase occurred on June 20, 2013 at a weighted average price of $1.15 per share. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.20 per share.
See Remarks